Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost.

Laughlin, Brady S; Silva, Alvin C; Vora, Sujay A; Keole, Sameer R; Wong, William W; Schild, Michael H; Schild, Steven E

Laughlin, Brady S; Silva, Alvin C; Vora, Sujay A; Keole, Sameer R; Wong, William W; Schild, Michael H; Schild, Steven E.

Afiliación

Laughlin BS; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.
Silva AC; Department of Radiology, Mayo Clinic, Phoenix, AZ, United States.
Vora SA; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.
Keole SR; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.
Wong WW; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.
Schild MH; Pinehurst Pathology Center, Pinehurst, NC, United States.
Schild SE; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States.

Front Oncol ; 12: 921465, 2022.

Article en En | MEDLINE | ID: mdl-36033460

Palabras clave

IMRT (intensity modulated radiation therapy); MRI; SIB; prostate cancer; radiation therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google